Cambrex announced today that its Snapdragon Chemistry company expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts. The expansion further supports the development and manufacturing of peptide therapies. East Rutherford, New Jersey-based Cambrex said its new GMP manufacturing suite increases the overall facility footprint by 20%. It also includes an ISO-7 cleanroom for preparative…
Asymchem scoops up Snapdragon Chemistry
The CDMO Asymchem Laboratories (Tianjin, China) Co., Ltd. has entered into an agreement to acquire Snapdragon Chemistry, a US-based chemical technology company. Asymchem will pay $57.94 million to acquire Snapdragon, which focuses on early-stage chemical process development services for the pharma and fine chemicals industries. “We believe continuous flow manufacturing is a revolutionary technology and…